Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Specific area of SARS-CoV-2 spike protein found to be a promising target for pan-coronavirus vaccine

Researchers at the Francis Crick Institute have shown that a specific area of the SARS-CoV-2 spike protein is a promising target for a pan-coronavirus vaccine that could offer some protection against new virus variants, common colds, and help prepare for future pandemics.

27 Jul 2022

India, Pakistan tackle backslide in child immunizations

India and other South Asian countries must deal with a dangerous backslide in routine infant vaccinations during 2019—2021 brought on by the COVID-19 pandemic and restrictions imposed to counter its spread, say UNICEF officials.

27 Jul 2022

Investigating an effective linear deoxyribonucleic acid COVID-19 vaccine option for domestic cats

In a new study, investigators studied a linear deoxyribonucleic acid (linDNA) SARS-CoV-2 vaccine option in felines.

27 Jul 2022

Increased resistance to human interferons could be a potential driver of SARS-CoV-2 evolution

Researchers compared the potency of 17 human interferons (IFNs) against multiple SARS-CoV-2 variants.

27 Jul 2022

Study shows SARS-CoV-2 impairs interferon production through NSP2-induced repression of mRNA translation

Researchers discovered a SARS-CoV-2 non-structural protein 2 (NSP2)-mediated mechanism by which it suppresses the production of interferon-beta (IFN-β) in host cells.

27 Jul 2022

Study shows the emerging Omicron sublineage BA.2.75 does not show greater immune evasion than BA.5

Researchers assessed the sensitivity of SARS-CoV-2 Omicron BA.2.75 variant to neutralizing antibodies.

27 Jul 2022

UK study finds over 100 symptoms of long COVID in non-hospitalized adults

In a new study, researchers determined symptoms and risk factors present beyond 12 weeks in non-hospitalized adults with confirmed SARS-CoV-2 infection.

27 Jul 2022

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Researchers assessed the biodistribution and safety of SBCoV202, a novel antiviral agent based on antisense technology that can specifically and effectively bind to the SARS-CoV-2 genome target to inhibit SARS-CoV-2 replication.

27 Jul 2022

Scientists explore post-COVID-19 conditions among children

Scientists evaluated post coronavirus disease 2019 conditions across children 90 days following COVID-19.

27 Jul 2022

Scientists explore associations between SARS-CoV-2 neutralizing antibodies and receptor-binding domain-selective proliferative memory CD4 T cells

Researchers depicted the correlations between receptor-binding domain (RBD)-selective proliferative memory CD4 T cells and neutralizing antibodies in COVID-19 vaccinees and convalescent patients.

27 Jul 2022

Temporal changes in CD4 T-lymphocyte dynamics upon immunization against SARS-CoV-2 spike protein

Researchers assessed changes in CD4 T-lymphocyte temporal dynamics by evaluating T-lymphocyte responses to SARS-CoV-2 S using Foxp3-Tocky mice and Nr4a3-Tocky mice.

27 Jul 2022

The neutralizing antibody response in mRNA vaccinated and boosted healthcare workers against major circulating SARS-CoV-2 Omicron subvariants

Researchers assessed the duration of the neutralizing antibody responses after SARS-CoV-2 mRNA booster vaccination.

27 Jul 2022

SARS-CoV-2 Omicron BA.5 neutralization in vaccinated individuals

Researchers assessed the duration of SARS-CoV-2 Omicron BA.5 neutralization in SARS-CoV-2 vaccinated persons.

27 Jul 2022

Study estimates prevalence of SARS-CoV-2 omicron breakthrough infections in South Africa

Scientists have described the prevalence of vaccine breakthrough SARS-CoV-2 infection in South Africa during the period of delta and omicron circulation.

27 Jul 2022

Population-based cohort study investigates the effect of SARS-CoV-2 infection on pregnancy outcomes

In a new study, researchers have focused on evaluating small-for-gestational-age rates and preterm birth in a large cohort.

27 Jul 2022

Listen: Can California lower the price of insulin?

California Healthline senior correspondent Angela Hart appeared on KCRW's "Press Play With Madeleine Brand" and KJZZ, a public radio station in Phoenix, this month to discuss California's plan to reduce the cost of some prescription medications — starting with insulin — by diving into the generic drug market.

27 Jul 2022

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

Researchers report the efficacy and safety of molnupiravir in treating COVID-19.

26 Jul 2022

Nasal spray highly effective against HIV and SARS-CoV-2 in animal models

The intranasal delivery of amph-protein vaccines is a potential approach to elicit a mucosal immune response against many infectious diseases.

26 Jul 2022

Three doses of Novavax vaccine effective against Omicron subvariants

Researchers report that Novavax COVID-19 vaccine triggers robust neutralization against SARS-CoV-2 Omicron subvariants.

26 Jul 2022

Researchers pinpoint multiple zoonotic origins of SARS-CoV-2

In a pair of related studies, published July 26, 2022 online via First Release in Science, researchers at University of California San Diego, with colleagues on four continents, show that the origin of the COVID-19 pandemic in 2019 was at the Huanan Seafood Wholesale Market in Wuhan, China, and resulted from at least two instances of the SARS-CoV-2 virus jumping from live animal hosts to humans working or shopping there.

26 Jul 2022

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Specific area of SARS-CoV-2 spike protein found to be a promising target for pan-coronavirus vaccine

India, Pakistan tackle backslide in child immunizations

Investigating an effective linear deoxyribonucleic acid COVID-19 vaccine option for domestic cats

Increased resistance to human interferons could be a potential driver of SARS-CoV-2 evolution

Study shows SARS-CoV-2 impairs interferon production through NSP2-induced repression of mRNA translation

Study shows the emerging Omicron sublineage BA.2.75 does not show greater immune evasion than BA.5

UK study finds over 100 symptoms of long COVID in non-hospitalized adults

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Scientists explore post-COVID-19 conditions among children

Scientists explore associations between SARS-CoV-2 neutralizing antibodies and receptor-binding domain-selective proliferative memory CD4 T cells

Temporal changes in CD4 T-lymphocyte dynamics upon immunization against SARS-CoV-2 spike protein

The neutralizing antibody response in mRNA vaccinated and boosted healthcare workers against major circulating SARS-CoV-2 Omicron subvariants

SARS-CoV-2 Omicron BA.5 neutralization in vaccinated individuals

Study estimates prevalence of SARS-CoV-2 omicron breakthrough infections in South Africa

Population-based cohort study investigates the effect of SARS-CoV-2 infection on pregnancy outcomes

Listen: Can California lower the price of insulin?

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

Nasal spray highly effective against HIV and SARS-CoV-2 in animal models

Three doses of Novavax vaccine effective against Omicron subvariants

Researchers pinpoint multiple zoonotic origins of SARS-CoV-2

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in